LoginGet started
Picture of Pharmarise Holdings logo

2796 — Pharmarise Holdings Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesConservativeMicro CapContrarian
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for Pharmarise Holdings, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.

2019
May 31st
2020
May 31st
2021
May 31st
2022
May 31st
2023
May 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line4008191,2021,3221,049
Depreciation
Amortisation
Non-Cash Items266325130214406
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-993-801-732-2,131-161
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities8961,5711,9447132,518
Capital Expenditures-458-457-552-466-542
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-43-277-524174-161
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-501-734-1,076-292-703
Financing Cash Flow Items-2-295-2—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities354-766-728-1,034-1,072
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash74971140-613743